European drug regulators have followed in the footsteps of their Australian and US counterparts, following the approval of Novartis’ new anti-VEGF therapy. Read more
Warby Parker launches its own contact lens
US-based online retailer of prescription spectacles Warby Parker has entered a new section of the ophthalmic market with its own brand of contact lenses. Read more
Lens makers leave the lab for rural bushfire response
A team of volunteers left the comfort of their optical laboratory for the charred, rugged landscapes of rural Victoria as part of efforts to aid the bushfire recovery. Read more
Ellex CEO steps down as company shifts to new business model
Further leadership changes have occurred at Ellex Medical Lasers with the resignation of its interim CEO, as the company prepares to offload its lasers and ultrasound business to focus on higher growth ophthalmic segments. Read more
Multi-million dollar Aussie project to cut optometry false-positive rate
Australian agencies are collaborating with technology firm Big Picture Medical in a $12 million project to develop an AI-assisted platform that could reduce inappropriate patient management at the primary point-of-care. Read more
Safilo introduces new David Beckham range to Australia
Safilo has officially launched the new David Beckham Eyewear collection in Australia, bringing a new range of sunglass and optical offerings to the premium male segment. Read more
Sunglass Collective combines international style with local service
The family team behind Eyes Right Optical have launched their latest venture, promising to bring a new level of style and service to the Australian and New Zealand eyewear sector. Read more
Luxottica supports bushfire-affected communities
Luxottica has pledged to donate up to $150,000 and is offering free replacement spectacles and lubricating eye drops as Australians count the cost of the ongoing bushfire disaster. Read more
Opthea hits recruitment target for diabetic study
Melbourne biopharmaceutical company Opthea has completed the patient recruitment phase for the latest trial of its novel therapy for diabetic macular edema (DME). Read more
French company to acquire Ellex assets in multi-million-dollar deal
Ellex Medical Lasers has agreed to sell its laser and ultrasound business segment to French company Lumibird Group for $100 million. Read more